Matches in SemOpenAlex for { <https://semopenalex.org/work/W4311463322> ?p ?o ?g. }
- W4311463322 endingPage "102496" @default.
- W4311463322 startingPage "102496" @default.
- W4311463322 abstract "Traditionally, the classification of breast cancer relies on the expression of immunohistochemical (IHC) biomarkers readily available in clinical practice. Using highly standardized and reproducible assays across patient cohorts, intrinsic molecular subtypes of breast cancer - also called intrinsic subtypes (IS) - have been identified based on the expression of 50 genes. Although IHC-based subgroups and IS moderately correlate to each other, they are not superimposable. In fact, non-luminal biology has been detected in a substantial proportion (5-20%) of hormone receptor-positive (HoR+) tumors, has prognostic value, and identifies reduced and increased sensitivity to endocrine therapy and chemotherapy, respectively. During tumor progression, a shift toward a non-luminal estrogen-independent and more aggressive phenotype has been demonstrated. Intrinsic genomic instability and cell plasticity, alone or combined with external constraints deriving from treatment selective pressure or interplay with the tumor microenvironment, may represent the determinants of such biological diversity between primary and metastatic disease, and during metastatic tumor evolution. In this review, we describe the distribution and the clinical behavior of IS as the disease progresses, focusing on HoR+/HER2-negative advanced breast cancer. In addition, we provide an overview of the ongoing clinical trials aiming to validate the predictive and prognostic value of IS towards their incorporation into routine care." @default.
- W4311463322 created "2022-12-26" @default.
- W4311463322 creator A5008991955 @default.
- W4311463322 creator A5014379154 @default.
- W4311463322 creator A5020241025 @default.
- W4311463322 creator A5043895722 @default.
- W4311463322 creator A5089513581 @default.
- W4311463322 date "2023-01-01" @default.
- W4311463322 modified "2023-10-14" @default.
- W4311463322 title "Clinical implications of the intrinsic molecular subtypes in hormone receptor-positive and HER2-negative metastatic breast cancer" @default.
- W4311463322 cites W1976022788 @default.
- W4311463322 cites W1986471913 @default.
- W4311463322 cites W1987545731 @default.
- W4311463322 cites W1999712770 @default.
- W4311463322 cites W2004337803 @default.
- W4311463322 cites W2013147142 @default.
- W4311463322 cites W2027554591 @default.
- W4311463322 cites W2045800222 @default.
- W4311463322 cites W2052303326 @default.
- W4311463322 cites W2069659635 @default.
- W4311463322 cites W2082833890 @default.
- W4311463322 cites W2088299041 @default.
- W4311463322 cites W2096283457 @default.
- W4311463322 cites W2097255042 @default.
- W4311463322 cites W2097698108 @default.
- W4311463322 cites W2105960180 @default.
- W4311463322 cites W2106292881 @default.
- W4311463322 cites W2106833357 @default.
- W4311463322 cites W2107617686 @default.
- W4311463322 cites W2119434445 @default.
- W4311463322 cites W2119878357 @default.
- W4311463322 cites W2122889158 @default.
- W4311463322 cites W2125702566 @default.
- W4311463322 cites W2131994307 @default.
- W4311463322 cites W2132619562 @default.
- W4311463322 cites W2135696440 @default.
- W4311463322 cites W2136879321 @default.
- W4311463322 cites W2141414987 @default.
- W4311463322 cites W2144442992 @default.
- W4311463322 cites W2153206149 @default.
- W4311463322 cites W2156756623 @default.
- W4311463322 cites W2157434805 @default.
- W4311463322 cites W2157840751 @default.
- W4311463322 cites W2161109798 @default.
- W4311463322 cites W2162765338 @default.
- W4311463322 cites W2166311434 @default.
- W4311463322 cites W2167188058 @default.
- W4311463322 cites W2168507982 @default.
- W4311463322 cites W2172741546 @default.
- W4311463322 cites W2226110706 @default.
- W4311463322 cites W2290950904 @default.
- W4311463322 cites W2319824849 @default.
- W4311463322 cites W2320248812 @default.
- W4311463322 cites W2414214572 @default.
- W4311463322 cites W2528767298 @default.
- W4311463322 cites W2552099557 @default.
- W4311463322 cites W2570752636 @default.
- W4311463322 cites W2591481727 @default.
- W4311463322 cites W2591810315 @default.
- W4311463322 cites W2598516659 @default.
- W4311463322 cites W2620993107 @default.
- W4311463322 cites W2621271973 @default.
- W4311463322 cites W2738090720 @default.
- W4311463322 cites W2760438050 @default.
- W4311463322 cites W2760540538 @default.
- W4311463322 cites W2762008780 @default.
- W4311463322 cites W2763875663 @default.
- W4311463322 cites W2765744530 @default.
- W4311463322 cites W2801511839 @default.
- W4311463322 cites W2804105316 @default.
- W4311463322 cites W2805575723 @default.
- W4311463322 cites W2806209829 @default.
- W4311463322 cites W2892043300 @default.
- W4311463322 cites W2896846857 @default.
- W4311463322 cites W2897147983 @default.
- W4311463322 cites W2912143634 @default.
- W4311463322 cites W2917464640 @default.
- W4311463322 cites W2944289287 @default.
- W4311463322 cites W2945564879 @default.
- W4311463322 cites W2948069739 @default.
- W4311463322 cites W2974027076 @default.
- W4311463322 cites W2977977567 @default.
- W4311463322 cites W2982150569 @default.
- W4311463322 cites W2994903788 @default.
- W4311463322 cites W2999400187 @default.
- W4311463322 cites W3000476524 @default.
- W4311463322 cites W3018222852 @default.
- W4311463322 cites W3069915980 @default.
- W4311463322 cites W3081315565 @default.
- W4311463322 cites W3088421575 @default.
- W4311463322 cites W3115380088 @default.
- W4311463322 cites W3119128530 @default.
- W4311463322 cites W3132563444 @default.
- W4311463322 cites W3133509869 @default.
- W4311463322 cites W3136964832 @default.
- W4311463322 cites W3140415241 @default.
- W4311463322 cites W3148345241 @default.
- W4311463322 cites W3162208650 @default.